OMEPRAZOLE MAGNESIUM | A206877 | AUROBINDO PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
AUROBINDO PHARMA LIMITED et al v. ASTRAZENECA AB et al 2 patentsANDA 206877omeprazole magnesium | D.N.J. | 2016-08-18 | Terminated 2017-09-21 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.4216
per ea
Lowest NADAC/Unit
$0.4216
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00536132213OMEPRAZOLE MAG DR 20 MG TABLET | $0.4216 | EA | Generic | — | 2026-06-17 |
| 00536132271OMEPRAZOLE MAG DR 20 MG TABLET | $0.4216 | EA | Generic | — | 2026-06-17 |
| 00536132288OMEPRAZOLE MAG DR 20 MG TABLET | $0.4216 | EA | Generic | — | 2026-06-17 |
| 70000052102OMEPRAZOLE MAG DR 20 MG TABLET | $0.4216 | EA | Generic | — | 2026-06-17 |
| 70000052103OMEPRAZOLE MAG DR 20 MG TABLET | $0.4216 | EA | Generic | — | 2026-06-17 |
| 70000052104OMEPRAZOLE MAG DR 20 MG TABLET | $0.4216 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.